Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Handheld Ultrasound Developer Exo Raised $220M In Series C

Executive Summary

As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date. 

You may also be interested in...



Minute Insight: What Is Going On With Butterfly Network’s Leadership?

Since going public, the company’s share price has flopped, its board has seen a flurry of appointments and resignations over the past year, and now the company is facing investor lawsuits.

Exec Chat: Clarius' Take On The Emerging Handheld Ultrasound Market

In an interview with Medtech Insight, Another newcomer to the handheld ultrasound market weighed in on the competitive environment.

Philips Steps Up Ultrasound Game With Lumify 4.0

The new version of Philips' Lumify gives clinicians access to pulse wave Doppler ultrasound technology, providing real-time blood flow information.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel